No matter how cynical the overall market is Vir Biotechnology Inc (VIR) performance over the last week is recorded -3.80%

On Tuesday, Vir Biotechnology Inc (NASDAQ: VIR) opened lower -5.69% from the last session, before settling in for the closing price of $10.20. Price fluctuations for VIR have ranged from $7.72 to $27.48 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Annual sales at Healthcare sector company grew by 421.39% over the past five years. Company’s average yearly earnings per share was noted 10.92% at the time writing. With a float of $88.00 million, this company’s outstanding shares have now reached $134.78 million.

Let’s look at the performance matrix of the company that is accounted for 587 employees.

Vir Biotechnology Inc (VIR) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vir Biotechnology Inc is 34.83%, while institutional ownership is 53.39%. The most recent insider transaction that took place on Apr 01 ’24, was worth 27,251. In this transaction EVP & Chief Technology Officer of this company sold 2,711 shares at a rate of $10.05, taking the stock ownership to the 132,069 shares. Before that another transaction happened on Mar 27 ’24, when Company’s EVP & Chief Financial Officer sold 6,008 for $9.89, making the entire transaction worth $59,404. This insider now owns 100,492 shares in total.

Vir Biotechnology Inc (VIR) Performance Highlights and Predictions

If we go through the results of last quarter, which was made public on 12/30/2023, the company posted -$0.86 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.01) by $0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.03 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 10.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.

Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators

Check out the current performance indicators for Vir Biotechnology Inc (VIR). In the past quarter, the stock posted a quick ratio of 9.05. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.07.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.59, a number that is poised to hit -1.05 in the next quarter and is forecasted to reach -3.97 in one year’s time.

Technical Analysis of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc (NASDAQ: VIR) saw its 5-day average volume 0.82 million, a negative change from its year-to-date volume of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 24.84%. Additionally, its Average True Range was 0.46.

During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 39.59%, which indicates a significant increase from 1.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.36% in the past 14 days, which was lower than the 53.59% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $10.18, while its 200-day Moving Average is $11.94. Nevertheless, the first resistance level for the watch stands at $9.86 in the near term. At $10.10, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.23. If the price goes on to break the first support level at $9.49, it is likely to go to the next support level at $9.36. Assuming the price breaks the second support level, the third support level stands at $9.12.

Vir Biotechnology Inc (NASDAQ: VIR) Key Stats

There are currently 135,032K shares outstanding in the company with a market cap of 1.30 billion. Presently, the company’s annual sales total 86,180 K according to its annual income of -615,060 K. Last quarter, the company’s sales amounted to 16,790 K and its income totaled -115,970 K.